During the past decade, Baptist Health System, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Baptist Health System, Inc." are "Acromegaly" (1 trials), "Arteriosclerosis" (1 trials) and "Intermittent Claudication" (1 trials). Many other conditions were trialed in "Baptist Health System, Inc." in a lesser frequency.

Most popular intervention types in "Baptist Health System, Inc." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "DNA Plasmid Vector" (1 trials), "EW-A-401 DNA Plasmid Vector" (1 trials) and "Lanreotide (Autogel formulation)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baptist Health System, Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Baptist Health System, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Baptist Health System, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baptist Health System, Inc., 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".